List of Tables
Summary Table: Global Market for Neuroprosthetics, by Product Type, Through 2028
Table 1: Impairments Due to Dysfunction or Damaged Neurons
Table 2: U.S. FDA Device Classification of Neuroprosthetics
Table 3: Public Agency Funding/Initiatives, Neuroprosthetic Advancements
Table 4: Funds Raised, by Selected BCI Companies
Table 5: Factors Impacting Neuroprosthetics Market
Table 6: BCI Signal Acquisition Technologies
Table 7: BCI Industry Overview
Table 8: Motor Impairments and Prevalence
Table 9: Sensory Impairments and Prevalence
Table 10: Global Market for Neuroprosthetics, by Product Type, Through 2028
Table 11: Global Hearing Loss Prevalence, by WHO Region, 2019
Table 12: Global Market for Cochlear Implants, by Region, Through 2028
Table 13: Global Market for DBS, by Region, Through 2028
Table 14: Global Market for Neuroprosthetics for Movement Restoration, by Region, Through 2028
Table 15: Global Market for Bladder and Bowel Control Implants, by Region, Through 2028
Table 16: Global Market for Other Neuroprosthetics, by Region, Through 2028
Table 17: Global Market for Neuroprosthetics, by Application, Through 2028
Table 18: Global Market for Neuroprosthetics for Nervous System Function Replacement, by Region, Through 2028
Table 19: Global Market for Neuroprosthetics for Nervous System Modulation, by Region, Through 2028
Table 20: Global Market for Neuroprosthetics, by Region, Through 2028
Table 21: North American Market for Neuroprosthetics, by Product Type, Through 2028
Table 22: North American Market for Neuroprosthetics, by Application, Through 2028
Table 23: North American Market for Neuroprosthetics, by Country, Through 2028
Table 24: European Market for Neuroprosthetics, by Product Type, Through 2028
Table 25: European Market for Neuroprosthetics, by Application, Through 2028
Table 26: European Market for Neuroprosthetics, by Country, Through 2028
Table 27: Asia-Pacific Market for Neuroprosthetics, by Product Type, Through 2028
Table 28: Asia-Pacific Market for Neuroprosthetics, by Application, Through 2028
Table 29: Asia-Pacific Market for Neuroprosthetics, by Country, Through 2028
Table 30: RoW Market for Neuroprosthetics, by Product Type, Through 2028
Table 31: RoW Market for Neuroprosthetics, by Application, Through 2028
Table 32: Critical ESG Factors in Neuroprosthetics
Table 33: Major Neuroprosthetics Achievements: Key ESG Focus Areas
Table 34: ESG Rankings of Major Neuroprosthetics Companies, 2023*
Table 35: CDP Scope Card for Major Neuroprosthetics Companies, 2022
Table 36: Selected Significant Developments in BCI Technology
Table 37: Selected Cochlear Implants in Clinical Trial
Table 38: Selected BCI Neuroprosthetics in Clinical Trial
Table 39: Selected FES Neuroprosthetics in Clinical Trial
Table 40: Selected DBS in Clinical Trial
Table 41: Selected Bladder and Bowel Control Implants in Development
Table 42: Selected Visual Prosthetics in Development
Table 43: Market Leader Cochlear Implants Product Portfolio
Table 44: Currently Available: Deep Brain Stimulators (DBSs)
Table 45: Currently Available: Bladder and Bowel Control Implants
Table 46: Selected Neuroprosthetics for Movement Restoration
Table 47: Currently Available Diaphragm Pacing System
Table 48: M&A in the Neuroprosthetics Market Jan. 2021-May 2023
Table 49: Abbott Laboratories: Financials, 2022
Table 50: Abbott Laboratories: Neuroprosthetics Portfolio
Table 51: Abbott Laboratories: News/Key Developments, Jan 2021-June 2023
Table 52: Axonics Inc.: Financials, 2022
Table 53: Axonics Inc.: Neuroprosthetics Portfolio
Table 54: Axonics Inc.: News/Key Developments, Jan. 2022-June 2023
Table 55: Bioventus: Financials, 2022
Table 56: Bioventus: Neural Prosthetics Portfolio
Table 57: Bioventus: News/Key Developments, Jan. 2021-June 2023
Table 58: Blackrock Neurotech: Product Portfolio
Table 59: Blackrock Neurotech: News/Key Developments, Jan. 2021-June 2023
Table 60: Boston Scientific Corp.: Financials, 2022
Table 61: Boston Scientific Corp.: Neuroprosthetics Portfolio
Table 62: Boston Scientific Corp.: News/Key Developments, Jan. 2021-June 2023
Table 63: Cochlear Ltd.: Financials, 2022
Table 64: Cochlear Ltd.: Neural Prosthetics Portfolio
Table 65: Cochlear Ltd.: News/Key Developments, Jan. 2021-June 2023
Table 66: Cyberdyne Inc.: Financials, 2022*
Table 67: Cyberdyne Inc.: Neural Prosthetics Portfolio
Table 68: MED EL: Neuroprosthetics Portfolio
Table 69: Medtronic: Financials, 2022
Table 70: Medtronic: Neuroprosthetics Portfolio
Table 71: Medtronic: News/Key Developments, Jan. 2021-June 2023
Table 72: NeuroPace Inc.: Financials, 2022
Table 73: NeuroPace Inc.: Neuroprosthetic Portfolio
Table 74: NeuroPace Inc.: News/Key Developments, Jan. 2018-June 2023
Table 75: Paradromics: News/Key Developments, Dec. 2020-June 2023
Table 76: Sonova: Financials, 2022
Table 77: Sonova: Neural Prosthetics Portfolio
Table 78: Sonova: News/Key Developments, Dec. 2020-June 2023
Table 79: Synchron: News/Key Developments, Jan. 2020-June 2023
Table 80: Acronyms
List of Figures
Summary Figure A: Global Market for Neuroprosthetics, by Product Type, 2020-2028
Summary Figure B: Global Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 1: Percentage of Disability, Adults 18+, U.S., 2019
Figure 2: Granted Breakthrough Device Designations (BDD), by Clinical Panel, As of March 31, 2023
Figure 3: DBS Primary Treatment: Patient Shares, by Indication
Figure 4: Leading Cause of Paralysis
Figure 5: Stroke and Associated Burden on Healthcare System in U.S., Europe and Canada
Figure 6: BCI Device Steps
Figure 7: BCI Signal Acquisition Technologies, by Type
Figure 8: Advantages of Brain-Controlled Prosthetic Limbs
Figure 9: Global Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 10: Global Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 11: Hearing Loss Prevalence, by Age Group, 2019
Figure 12: Global Market for Cochlear Implants, by Region, 2020-2028
Figure 13: Global Market Shares of Cochlear Implants, by Region, 2022
Figure 14: Global Market for DBS, by Region, 2020-2028
Figure 15: Global Market Shares of DBS, by Region, 2022
Figure 16: Global Market for Neuroprosthetics for Movement Restoration, by Region, 2020-2028
Figure 17: Global Market Shares of Neuroprosthetics for Movement Restoration, by Region, 2022
Figure 18: Global Market for Bladder and Bowel Control Implants, by Region, 2020-2028
Figure 19: Global Market Shares of Bladder and Bowel Control Implants, by Region, 2022
Figure 20: Global Market for Other Neuroprosthetics, by Region, 2020-2028
Figure 21: Global Market Shares of Other Neuroprosthetics, by Region, 2022
Figure 22: Global Market for Neuroprosthetics, by Application, 2020-2028
Figure 23: Global Market Shares of Neuroprosthetics, by Application, 2022
Figure 24: Global Market for Neuroprosthetics for Nervous System Function Replacement, by Region, 2020-2028
Figure 25: Global Market Shares of Neuroprosthetics for Nervous System Function Replacement, by Region, 2022
Figure 26: Global Market for Neuroprosthetics for Nervous System Modulation, by Region, 2020-2028
Figure 27: Global Market Shares of Neuroprosthetics for Nervous System Modulation, by Region, 2022
Figure 28: Global Market for Neuroprosthetics, by Region, 2020-2028
Figure 29: Global Market Shares of Neuroprosthetics, by Region, 2022
Figure 30: Investment on Grants for Biomedical Research, by Region, in 2020
Figure 31: North American Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 32: North American Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 33: North American Market for Neuroprosthetics, by Application, 2020-2028
Figure 34: North American Market Shares of Neuroprosthetics, by Application, 2022
Figure 35: North American Market for Neuroprosthetics, by Country, 2020-2028
Figure 36: European Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 37: European Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 38: European Market for Neuroprosthetics, by Application, 2020-2028
Figure 39: European Market Shares of Neuroprosthetics, by Application, 2022
Figure 40: European Market for Neuroprosthetics, by Country, 2020-2028
Figure 41: Global Aging (60+) Population, by Region, 2015-2050
Figure 42: Asia-Pacific Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 43: Asia-Pacific Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 44: Asia-Pacific Market for Neuroprosthetics, by Application, 2020-2028
Figure 45: Asia-Pacific Market Shares of Neuroprosthetics, by Application, 2022
Figure 46: Asia-Pacific Market for Neuroprosthetics, by Country, 2020-2028
Figure 47: RoW Market for Neuroprosthetics, by Product Type, 2020-2028
Figure 48: RoW Market Shares of Neuroprosthetics, by Product Type, 2022
Figure 49: RoW Market for Neuroprosthetics, by Application, 2020-2028
Figure 50: RoW Market Shares of Neuroprosthetics, by Application, 2022
Figure 51: Selected Factors Driving ESG
Figure 52: How A Strong ESG Proposition Benefits Business
Figure 53: Five Key ESG Focus Areas, Neuroprosthetics, 2022
Figure 54: Emerging Trends/Technologies in the Neuroprosthetics Market
Figure 55: Advantages of The Networked Neuroprosthetic (NNP) System
Figure 56: Principle Competitive Factors in the Neuroprosthetics Market
Figure 57: Global Market Shares of Cochlear Implants, by Manufacturer, 2022
Figure 58: Global Market Shares of DBS, by Manufacturer, 2022
Figure 59: Global Market Shares of Bladder and Bowel Control Implants, by Manufacturer, 2022
Figure 60: Abbott Laboratories: Financials, 2021 and 2022
Figure 61: Abbott Laboratories: Revenue Shares, by Business Unit, 2022
Figure 62: Abbott Laboratories: Revenue Shares, by Region, 2022
Figure 63: Axonics Inc.: Financials, 2021 and 2022
Figure 64: Axonics Inc.: Revenue Shares, by Product, 2022
Figure 65: Axonics Inc.: Revenue Shares, by Region, 2022
Figure 66: Bioventus: Financials, 2021 and 2022
Figure 67: Bioventus: Revenue Shares, by Business Unit, 2022
Figure 68: Bioventus: Revenue Shares, by Region, 2022
Figure 69: Boston Scientific Corp.: Financials, 2021 and 2022
Figure 70: Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
Figure 71: Boston Scientific Corp.: Revenue Shares, by Region, 2022
Figure 72: Cochlear Ltd.: Financials, 2021 and 2022
Figure 73: Cochlear Ltd.: Revenue Shares, by Business Segment, 2022
Figure 74: Cochlear Ltd.: Revenue Shares, by Region, 2022
Figure 75: Cyberdyne Inc.: Financials, 2021 and 2022
Figure 76: Cyberdyne Inc.: Revenue Shares, by Business Type, 2022
Figure 77: Cyberdyne Inc.: Revenue Shares, by Region, 2022
Figure 78: Medtronic: Financials, 2021 and 2022
Figure 79: Medtronic: Revenue Shares, by Business Unit, 2022
Figure 80: Medtronic: Revenue Shares, by Region, 2022
Figure 81: NeuroPace Inc.: Financials, 2021 and 2022
Figure 82: Sonova: Financials, 2021 and 2022
Figure 83: Sonova: Revenue Shares, by Business Unit, 2022
Figure 84: Sonova: Revenue Shares, by Region, 2022
